| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
JBC, Vol. 252, Issue 9, 2992-2997, May, 1977
R. J. Koenig, S. H. Blobstein and A. Cerami
Hemoglobin AIc is a minor component of normal adult erythrocytes whose concentration is elevated approximately 2-fold in patients with diabetes mellitus. Previous work suggested that the unique structural feature of hemoglobin AIc is the presence of a low molecular weight sugar moiety at the NH2-terminal valine of the beta chain. In this study the structure of the carbohydrate moiety and the nature of its linkage of the beta chain were investigated. Enzymatic digestion of borohydride-reduced betaAIc chains followed by ion exchange chromatography led to the isolation of two distinct NH2-terminal glycovalylhistidines. Comparison of these glycodipeptides with synthetic glycovalylhistidines by thin layer chromatography, gas-liquid chromatography, and proton magnetic resonance spectroscopy gave direct evidence that the naturally derived materials correspond to glucitol and mannitol valylhistidines. Model reactions showed that glucose and mannose react with valine under mild conditions to form an adduct which upon sodium borohydride reduction yields in both cases glucitol and mannitol valines. This suggests a common intermediate, 1-deoxy-1-(N-valyl)fructose, for both reactions. From these studies we conclude that hemoglobin AIc has, as the NH2 terminus of the beta chain, 1-deoxy-1-(N-valyl)fructose. The possible biosynthetic pathways of hemoglobin AIc are discussed.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. W STITT Advanced glycation: an important pathological event in diabetic and age related ocular disease Br. J. Ophthalmol., June 1, 2001; 85(6): 746 - 753. [Full Text] [PDF]
|
|
|
|
 |
|
 E. S Kilpatrick Glycated haemoglobin in the year 2000 J. Clin. Pathol., May 1, 2000; 53(5): 335 - 339. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Al-Abed, T. Mitsuhashi, H. Li, J. A. Lawson, G. A. FitzGerald, H. Founds, T. Donnelly, A. Cerami, P. Ulrich, and R. Bucala Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioprotective effect of ethanol PNAS, March 2, 1999; 96(5): 2385 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bierhaus, M. A Hofmann, R. Ziegler, and P. P Nawroth AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept Cardiovasc Res, March 1, 1998; 37(3): 586 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wrobel, K. Wrobel, Ma. E. Garay-Sevilla, L. E. Nava, and J. M. Malacara Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system Clin. Chem., September 1, 1997; 43(9): 1563 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z Makita, H Vlassara, E Rayfield, K Cartwright, E Friedman, R Rodby, A Cerami, and R Bucala Hemoglobin-AGE: a circulating marker of advanced glycosylation Science, October 23, 1992; 258(5082): 651 - 653. [Abstract] [PDF]
|
|
|
|
|
|
H. Bunn and P. Higgins Reaction of monosaccharides with proteins: possible evolutionary significance Science, July 10, 1981; 213(4504): 222 - 224. [Abstract] [PDF]
|
|
|
|
|
|
V. Monnier and A Cerami Nonenzymatic browning in vivo: possible process for aging of long-lived proteins Science, January 30, 1981; 211(4481): 491 - 493. [Abstract] [PDF]
|
|
|
|
|
|
H. Bunn, K. Gabbay, and P. Gallop The glycosylation of hemoglobin: relevance to diabetes mellitus Science, April 7, 1978; 200(4337): 21 - 27. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
